General Notices

• Notice of Technical Assistance Webinar for NOT-EB-22-001 - Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health
  (NOT-EB-23-001)
  National Institute of Biomedical Imaging and Bioengineering
  

• Notice of Pre-Application and Technical Assistance Webinar for RFA-MH-23-115 and RFA-MH-23-116 "Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 and R21 Clinical Trial Optional)"
  (NOT-MH-23-180)
  National Institute of Mental Health
  

• Start Planning Your 2023 NIH Grants Conference Experience - Free, Virtual Event on February 1 and 2 - Register Today!
  (NOT-OD-23-064)
  National Institutes of Health
  

Notice of Changes to Funding Opportunities

• Notice of Correction to RFA-AR-24-001, "NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed)"
  (NOT-AR-23-013)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of Correction to the Non-responsive Application Criteria in PAR-22-174: Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
  (NOT-CA-23-039)
  National Cancer Institute
  

• Notice of Correction to the Non-responsive Application Criteria in PAR-22-173: Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
  (NOT-CA-23-040)
  National Cancer Institute
  

• Notice of Correction to NOT-ES-23-001"Need to Expire and Reissue RFA-ES-22-001 Maintaining and Enriching Environmental Epidemiology Cohorts to Support Scientific and Workforce Diversity (U24 Clinical Trial Not Allowed) to Clarify Review Criteria
  (NOT-ES-23-004)
  National Institute of Environmental Health Sciences
  

• Notice to Extend the Letter of Intent and Application Due Date for RFA-FD-23-006 - Applied Regulatory Science Research to Understand Factors that Affect the Safety and Efficacy of Underrepresented Populations in Oncology Therapeutic Development (U01)
  (NOT-FD-23-005)
  Food and Drug Administration
  

• Notice of Extension of NOT-HL-21-030 "Notice of Special Interest (NOSI): Heart, Lung, Blood and Sleep Focused Ancillary Studies to Large Ongoing Clinical Studies (Revised)"
  (NOT-HL-23-071)
  National Heart, Lung, and Blood Institute
  

• Notice of Change to RFA-PM-23-002, Small Grants to Enhance the Use of the All of Us Research Programs Data (R03 Clinical Trial Not Allowed)
  (NOT-PM-23-007)
  Office of the Director, NIH
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Research on the Etiology, Early Detection, Screening and Prevention of Early-Onset Colorectal Cancer
  (NOT-CA-23-018)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): Career Development Opportunities for Research Within the Mission of the Division of Cancer Prevention at the National Cancer Institute
  (NOT-CA-23-035)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): Technology Development for Cancer Control and Population Science Research
  (NOT-CA-23-037)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): Understanding Sudden Death in the Young Through Research
  (NOT-HL-22-040)
  National Heart, Lung, and Blood Institute
  National Institute of Neurological Disorders and Stroke
  

• Notice of Special Interest (NOSI): Computational and Statistical Methods to Enhance Discovery from Health Data
  (NOT-LM-23-001)
  National Library of Medicine
  

• Notice of Special Interest (NOSI): Priority Research Opportunities in Crisis Response Services
  (NOT-MH-23-140)
  National Institute of Mental Health
  National Institute on Drug Abuse
  Office of Research on Women's Health
  

Funding Opportunities

• Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)
  (PA-23-080)
  National Institutes of Health
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Deafness and Other Communication Disorders
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)
  (RFA-ES-23-004)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Pediatric Device Consortia Grants Program (P50) Clinical Trials Optional
  (RFA-FD-23-024)
  Food and Drug Administration
  Application Receipt Date(s): March 29, 2023